Literature DB >> 27402365

The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis.

Lele Song1,2, Yuemin Li3.   

Abstract

Stems cells of the colon crypt are the origin of colon mature cells. Colorectal cancer cells are also suggested to originate from crypt stem cells undergoing a series of epigenetic and genetic alterations. Aberrant methylation plays important roles in early carcinogenesis and lead to altered gene expression and regulation, resulting in accumulation of damages to cell function and ultimately, malignant transformation. Aberrances in hypermethylation and hypomethylation act in different mechanism through the regulation of various genes during CSC carcinogenesis, and both of them play crucial roles in stem cell differentiation towards cancer cells. A large majority of epigenetic and genetic abnormalities that work coordinately in colorectal carcinogenesis are related to cell growth and division, indicating that the intrinsic abnormalities of CRC lie in dysregulation of basic cellular processes. Detection of abnormal methylation can be used in cancer screening and early detection, while reversal of aberrant methylation using drugs may have potential in cancer therapy. This review will provide an overview on the roles of aberrant methylation and a summary of genes that are affected during CRC carcinogenesis.

Entities:  

Keywords:  Adenoma; Cancer stem cell; Colorectal cancer; Hypermethylation; Hypomethylation; Methylation; SEPT9; Stem cell

Mesh:

Year:  2016        PMID: 27402365     DOI: 10.1007/s12015-016-9672-6

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  132 in total

1.  Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.

Authors:  Christian Gerecke; Bettina Scholtka; Yvonne Löwenstein; Isabel Fait; Uwe Gottschalk; Dorothee Rogoll; Ralph Melcher; Burkhard Kleuser
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-23       Impact factor: 4.553

Review 2.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

3.  Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains.

Authors:  Jennifer J Trowbridge; Amit U Sinha; Nan Zhu; Mingjie Li; Scott A Armstrong; Stuart H Orkin
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

4.  Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation.

Authors:  Gillian R Wasson; Angela P McGlynn; Helene McNulty; Sharleen L O'Reilly; Valerie J McKelvey-Martin; George McKerr; J J Strain; John Scott; C Stephen Downes
Journal:  J Nutr       Date:  2006-11       Impact factor: 4.798

Review 5.  Stem cells and their implications for colorectal cancer.

Authors:  Sebastian S Zeki; Trevor A Graham; Nicholas A Wright
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

6.  DNA methylation and genetic instability in colorectal cancer cells.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer.

Authors:  Yuki I Kawamura; Minoru Toyota; Rei Kawashima; Teruki Hagiwara; Hiromu Suzuki; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino; Reiji Kannagi; Taeko Dohi
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

8.  Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.

Authors:  Hu Zhang; You-Qing Zhu; Ya-Qiong Wu; Ping Zhang; Jian Qi
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.

Authors:  Kenji Hibi; Makiko Sakata; Kazuma Sakuraba; Atsushi Shirahata; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada
Journal:  Anticancer Res       Date:  2008 May-Jun       Impact factor: 2.480

10.  Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer.

Authors:  Kenji Hibi; Hiroki Mizukami; Atsushi Shirahata; Tetsuhiro Goto; Makiko Sakata; Yutaka Sanada
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

View more
  5 in total

Review 1.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

2.  FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathways.

Authors:  Yan-Feng Huang; Wen-Bo Niu; Rong Hu; Ling-Jun Wang; Zeng-Yan Huang; Shi-Hao Ni; Ming-Qing Wang; Yi Yang; Yu-Sheng Huang; Wen-Jun Feng; Wei Xiao; Da-Jian Zhu; Shao-Xiang Xian; Lu Lu
Journal:  Oncogenesis       Date:  2018-10-02       Impact factor: 7.485

3.  Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia.

Authors:  Adam S Neal; Miguel Nunez; Tiffany Lai; Anela Tosevska; Marco Morselli; Malaika Amneus; Mae Zakhour; Neda A Moatamed; Matteo Pellegrini; Sanaz Memarzadeh
Journal:  Reprod Sci       Date:  2020-03-02       Impact factor: 3.060

4.  Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma.

Authors:  Yurika Kotoh; Yutaka Suehiro; Issei Saeki; Tomomi Hoshida; Masaki Maeda; Takuya Iwamoto; Toshihiko Matsumoto; Isao Hidaka; Tsuyoshi Ishikawa; Taro Takami; Shingo Higaki; Ikuei Fujii; Chieko Suzuki; Yoshitaro Shindo; Yukio Tokumitsu; Hiroaki Nagano; Isao Sakaida; Takahiro Yamasaki
Journal:  Hepatol Commun       Date:  2020-01-02

5.  FLRT2 functions as Tumor Suppressor gene inactivated by promoter methylation in Colorectal Cancer.

Authors:  Xiaohong Guo; Chao Song; Lei Fang; Min Li; Longtao Yue; Qing Sun
Journal:  J Cancer       Date:  2020-10-23       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.